|
Congratulations to five KI researchers that have been awarded Mayo Clinic and Karolinska Institutet Collaborative Cancer Research grants.
Galina Selivanova, Professor of Cell and Tumor Biology, Karolinska Institutet and Keith Knutson, Professor of Immunology, Mayo Clinic Florida for a project entitled “Mutant p53 as a target to improve response to immune checkpoint blockade”
Klas Wiman, Professor of Molecular Cell and Tumor Biology, Karolinska Institutet and Mrinal Patnaik, M.B.B.S., Associate Professor of Medicine, Mayo Clinic Rochester for a project “Pseudo-Mutant p53: a Predictor of Leukemic Transformation in Clonal Hematopoiesis”
Mikael Eriksson, PhD, Karolinska Institutet and Celine Vachon, Professor of Epidemiology, Mayo Clinic Rochester for a project entitled “Artificial intelligence image-based model development and validation for long-term breast cancer risk assessment in Swedish and U.S. screening setting”
Qiang Pan-Hammarström, Professor of Clinical Immunology, Karolinska Institutet and Zhi Zhang Yang, M.D., Assistant Professor of Medicine, Mayo Clinic Rochester for a project entitled “Development of targeted immunotherapy for malignant B cell lymphomas”
Richard Rosenquist Brandell, Professor of Clinical Genetics, Karolinska Institutet and Neil Kay, M.D., Professor of Medicine, Mayo Clinic for a project entitled "Multi-Omics Studies of BTK Inhibitor Resistance in Chronic Lymphocytic Leukemia”
Also, two projects awarded in 2021 were extended for the second year of funding for their collaborative breast cancer research projects.
Urban Lendahl, Professor of Genetics, and Antonio D’Assoro, M.D., Associate Professor of Pharmacology, “Novel NOTCH3-Based Therapies to Inhibit the Growth and Immune Evasion Capacity of Triple-Negative Breast Cancer”
Arne Östman, Professor in Molecular Oncology and Derek Radisky, Professor of Cancer Biology, “Exploration of fibroblasts as biologically relevant biomarkers in breast benign disease”
Learn more about the grant.
|
